About Rgenta Therapeutics
Rgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
Cambridge, United States
Year Founded
2019
Team Size
11-50
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
rgentatx.com
Domain Registered Date
Apr 4, 2018
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $52,000,000 · Series-A
fundraisingfox.com
- Capital Raise
Seed announced
- Milestone
X account created (@RgentaTx)
40 followers
- Milestone
Company founded
Cambridge, United States
- Milestone
Website domain registered
rgentatx.com
Investors & Backers
AstraZeneca
Boehringer Ingelheim Venture Fund
CICC
Delos Capital
Highlight Capital
Kaitai Capital
Korean Investment Partners
Legend Star
Lilly Asia Ventures
Matrix Partners China
The Leukemia & Lymphoma Society’s Therapy Acceleration Program
Vivo Capital
Funding History
Series-A
· Nov 29, 2022
$52,000,000 fundraisingfox.com
Seed
· May 25, 2021
Undisclosed Source
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026